XPEV Market Cap

XPeng Inc. American depositary shares, each representing two Class A ordinary shares · Market Cap

XPEV logo

XPEV Market Cap

Current$9.25B
XPEV Market Cap ($21.65B → $9.25B · CAGR -12.9%)
High-resolution chart · PNG

XPEV market cap history

Daily history. Dates identify market observations.

XPeng Inc. American depositary shares, each representing two Class A ordinary shares Market Cap — Daily history
DateMarket Cap
9,250,887,381
8,749,568,459
8,768,568,607
9,148,571,580
8,949,070,020
9,262,572,472
9,172,321,766
9,433,573,810
9,376,573,364
9,015,570,540
9,110,571,283
9,082,071,060
8,930,069,871
8,787,568,756
8,949,070,020
9,082,071,060
8,996,570,391
9,452,573,959
9,614,075,223
9,737,576,189
9,775,576,486
9,927,577,676
9,946,577,824
10,089,078,939
10,070,078,791
9,823,076,858
9,709,075,966
10,174,579,608
10,013,078,345
9,823,076,858
10,041,578,568
10,383,581,243
10,402,581,392
10,583,082,804
10,526,082,358
10,611,583,027
10,792,084,440
10,896,585,257
10,768,334,254
11,124,587,041
11,020,086,224
10,592,582,879
11,585,340,646
11,400,089,197
11,390,589,123
11,153,087,264
11,590,090,683
11,115,086,967
11,191,087,562
11,129,337,078
11,286,088,305
11,400,089,197
11,523,590,163
11,096,086,818
11,195,837,599
11,447,589,568
11,751,591,947
12,350,096,630
12,074,594,474
12,074,594,474
11,713,591,650
12,122,094,846
12,122,094,846
12,663,599,083
12,663,599,083
12,530,598,042
12,853,600,569
13,338,104,360
13,091,102,428
12,692,099,306
12,302,596,258
12,302,596,258
12,378,596,853
12,331,096,481
12,511,597,894
12,511,597,894
12,882,100,792
12,426,097,225
12,920,101,090
12,578,098,414
12,160,095,143
11,580,590,609
11,856,092,765
11,856,092,765
12,122,094,846
12,682,599,231
12,549,598,191
12,445,097,373
12,759,549,834
13,148,102,874
13,765,607,705
13,765,607,705
13,765,607,705
14,117,110,455
14,706,115,064
15,038,617,665
15,152,618,557
15,969,624,950
16,587,129,781
16,591,879,819
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.